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Abstract
PDZ (Post-synaptic density, 95 kDa, Discs large, Zona Occludens-1) domains are protein interaction domains that bind to the
carboxy-terminal amino acids of binding partners, heterodimerize with other PDZ domains, and also bind
phosphoinositides. PDZ domain containing proteins are frequently involved in the assembly of multi-protein complexes
and clustering of transmembrane proteins. LNX1 (Ligand of Numb, protein X 1) is a RING (Really Interesting New Gene)
domain-containing E3 ubiquitin ligase that also includes four PDZ domains suggesting it functions as a scaffold for a multi-
protein complex. Here we use a human protein array to identify direct LNX1 PDZ domain binding partners. Screening of
8,000 human proteins with isolated PDZ domains identified 53 potential LNX1 binding partners. We combined this set with
LNX1 interacting proteins identified by other methods to assemble a list of 220 LNX1 interacting proteins. Bioinformatic
analysis of this protein list was used to select interactions of interest for future studies. Using this approach we identify and
confirm six novel LNX1 binding partners: KCNA4, PAK6, PLEKHG5, PKC-alpha1, TYK2 and PBK, and suggest that LNX1
functions as a signalling scaffold.
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Introduction
PDZ domains are protein interaction domains often found in
molecules involved in signal transduction, cell polarity and
synaptic transmission. PDZ domains were first found to recognize
the extreme carboxy-terminal tail of target molecules by
recognizing the last few amino acids as well as the terminal
carboxylate residue [1]. PDZ domains have since been found to
recognize other PDZ domains, internal sequences within targets,
and phosphoinositides [2–4]. Proteins that contain PDZ domains
often have multiple copies with distinct binding specificities and
function as scaffolds in multiprotein complexes [5,6].
LNX1 and LNX2 are RING finger domain-containing E3
ubiquitin ligases that each contain four PDZ domains [7]. Murine
Lnx1 mRNA is expressed in brain, heart, lung, skeletal muscle and
kidney [8]. Human LNX1 mRNA is similarly expressed in brain,
heart, kidney as well as placenta and pancreas [9]. Murine Lnx2 is
more widely expressed and mRNA is detected in liver, spleen,
lung, heart, kidney, thymus, skeletal muscle and brain [10]. In a
pair-wise yeast two-hybrid assay, LNX1 has been shown to be able
to interact with itself and LNX2 [10].
LNX1 was first identified as a binding partner of the cell-fate
determinant Numb. The Numb phosphotyrosine binding (PTB)
domain binds specifically to an NPXY motif found between the
RING domain and the first PDZ domain (Figure 1) [8]. LNX1
mediates ubiquitination of Numb in vitro and targets specific Numb
isoforms for degradation in vivo [7]. The four mammalian Numb
isoforms differ by the presence or absence of two inserts, one in the
amino terminal PTB domain and the other in the central proline
rich region (PRR) [11]. LNX1 preferentially ubiquitinates the p72
and p66 isoforms, which contain the insert in the PTB domain,
and a unique PDZ-PTB domain interaction contributes to the
recognition of Numb for ubiquitination and degradation. [12].
The other PDZ domains of LNX1 have been shown to bind the
cytoplasmic tail of transmembrane proteins including CAR
(Coxsackievirus and Adenovirus Receptor), a tight junction
protein that is important for viral binding to target cells [13–16],
and Junctional Adhesion Molecule 4 (JAM4), an immunoglobulin
superfamily member that is found at tight junctions [17,18] and is
redistributed during epithelial-to-mesenchymal transition [19,20].
As well, the tight junction transmembrane protein, Claudin-1, has
also been shown to interact through its carboxy-terminus with a
region of LNX1 that includes all four PDZ domains [21]. In
addition, LNX1 also binds ErbB2, a member of the Epidermal
Growth Factor (EGF) Receptor family [22]. The second PDZ
domain of LNX1 mediates the interactions with ErbB2, CAR and
JAM4 [16,20,22]. Thus, LNX1 PDZ domains recognize the
carboxy termini of several different transmembrane proteins.
A number of cytosolic proteins have also been identified as
LNX1 PDZ binding proteins. A yeast two-hybrid screen to identify
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identified LNX1 [23–25]. The second PDZ domain of LNX1 was
found to recognize the CAST carboxy terminus [25]. A yeast two-
hybrid screen with LNX1 PDZ1 identified the transcription and
splicing factor SKIP (Ski-interacting protein) [26]. In addition, a
screen for binding partners for the potential PDZ recognition
motif found in the proto-oncogene Src identified LNX1 PDZ3
[27]. In vitro, both PDZ1 and PDZ3 were able to interact with Src
[27]. Recently a yeast two-hybrid screen for interaction partners of
the small GTPase, RhoC, identified LNX1 and the PDZ1 domain
was shown to be necessary for efficient binding to RhoC [28].
Finally, a yeast two-hybrid screen for Np9 interacting proteins
identified three PDZ domain containing proteins, one of which
was LNX1 [29]. Together, these individual studies demonstrate
that LNX1 PDZ domains have distinct transmembrane and
cytoplasmic binding partners and suggest that LNX1 may function
as a molecular scaffold.
The first PDZ domain of LNX1 is known to recognize four
cytoplasmic proteins, Numb, SKIP, RhoC and Src, two of which
(Numb and Src) have also been identified as LNX1 ubiquitination
substrates [7,27]. The second PDZ domain of LNX1 is able to
recognize the carboxy terminal tail of several different transmem-
brane proteins as well as one cytosolic protein, CAST. Thus far,
Src is the only protein identified that interacts with the third PDZ
domain of LNX1 and no interactions have been shown to involve
the fourth PDZ domain of LNX1. Despite the number of potential
protein-protein interactions identified for LNX1 to date, the lack
of functional interrelationships between these interactors means
that the cellular role of LNX1 is not well understood.
The arrangement of modular domains in LNX1 and their
ability to recognize a wide variety of target proteins suggest that it
acts as a scaffold molecule for a multiprotein signalling complex.
In order to further elucidate the activities of LNX1 in the cell, we
performed a protein array screen using the individual PDZ
domains of LNX1 and identified 53 LNX1 interactors. These
potential interactors were combined with the LNX1 interactors
described above and predicted interactions mined from other
high-throughput screens. Further bioinformatic and experimental
analyses suggest that LNX1 functions as a membrane targeted
scaffold protein involved in the assembly of signalling complexes
regulated by ubiquitylation.
Materials and Methods
Expression and Purification of GST Fusion Proteins
The individual PDZ domains of hLNX1 were subcloned by
PCR to create pEXP15-hLNX1 PDZ1 (aa 222–380), pEXP15-
hLNX1 PDZ2 (aa 373–466), pEXP15-hLNX1 PDZ3 (aa 498–
597), and pEXP15-hLNX1 PDZ4D3C (with last 3 amino acids
deleted to remove a PDZ binding motif) (aa 630–725). Each
pEXP15-hLNX1 PDZ construct was transformed into BL21-AI
cells (Invitrogen, Carlsbad, CA) and induced to express GST
fusion protein by the addition of 0.2% arabinose. Optimal
expression was found under the following induction conditions:
for pEXP15-hLNX1 PDZ1 3 h at 30uC; for pEXP15-hLNX1
PDZ2 3 h at 37uC, for pEXP15-hLNX1 PDZ3 and pEXP15-
hLNX1 PDZ4D3C 1 h at 30uC followed by overnight at 4uC (no
shaking). After induction, cells were pelleted and resuspended in
PBS++++ (phosphate buffered saline, 1% Triton-X-100, 1%
Tween-20, 1 mM dithiothreitol, CompleteH EDTA-free protease
inhibitor cocktail tablets (Roche Diagnostics, Indianapolis, IN)) at
10 mL of buffer/50 mL of culture. Resuspended cells were
sonicated three times at 4uC for 30 s using 1 s on/1 s off pulsing.
Sonicated cells were centrifuged for 10 minutes at 10,000 rpm in a
Beckmann centrifuge rotor JA25.5. Supernatant was incubated
with glutathione sepharose beads for 30–60 minutes at 4uC with
rotation. Beads were washed 5 times with PBS++++. After
washing, beads were resuspended in an equal volume of PBS++++.
As needed, GST fusion proteins were eluted from glutathione
sepharose beads using 3 incubations with gentle mixing at 4uC
with 10 mM glutathione in 50 mM Tris buffer pH 8.0. The
concentration of fusion protein in each elution was estimated by
running a 10 uL sample in 12.5% SDS-PAGE and comparing to
known quantities of bovine serum albumin (BSA). Elutions
containing sufficient amounts of protein were combined and
dialysed overnight at 4uC against 16PBS using Thermo Scientific
Dialysis Cassettes (Slide-a-lyzers) with 10,000 molecular weight
cut-off (Rockford, IL). The final concentration of eluted, dialyzed
fusion protein was estimated by running a 10 uL sample in 12.5%
SDS-PAGE and comparison to known quantities of BSA.
Fluorescent Labelling of Purified Fusion Proteins
The Molecular Probes MP30009 Alexa Fluor 647 Microscale
Protein Labelling Kit from Invitrogen (Carlsbad, CA) was used to
fluorescently label approximately 20 ug of eluted and dialyzed
fusion proteins GST-hLNX1 PDZ2, GST-hLNX1 PDZ3 and
GST-hLNX1-PDZ4D3C according to the manufacturer’s instruc-
tions (Figure S1). The amount of GST-hLNX1 PDZ1 produced
was insufficient for labeling with Alexa-647.
Protein Array Screens
In order to confirm that LNX1 PDZ domains were able to
recognize known interactors in a protein array format, custom
arrays were printed and screened. Regions of Numb (Entrez Gene
ID 18222), either containing (PTB+) or lacking (PTB2)a n1 1
amino acid insert in the PTB region, were utilized. GST, GST-
Numb PTB+ and GST-Numb PTB- were printed in rows at the
following concentrations (ng/uL): 250, 125, 63, 32, 16, 8, 4. Each
row also contained a blank spot identified as 0 ng/uL. This pattern
of immobilized fusion proteins was repeated to create 12 sub-arrays
per slide. We tested 0.05 ug, 0.10 ug and 0.20 ug of GST-hLNX1
PDZ2, GST-hLNX1 PDZ3 and GST-hLNX1 PDZ4D3C each
individually and a combination of 0.05 ug, 0.10 ug and 0.20 ug of
each of GST-hLNX1 PDZ2, GST-hLNX1 PDZ3 and GST-
hLNX1 PDZ4D3C mixed together each on their own sub-array.
Optimized conditions were used to incubate the mixture of
GST-hLNX1 PDZ2, PDZ3 and PDZ4D3C with duplicate
Invitrogen human ProtoArrayH v4 slides. Briefly, slides were
rinsed with PBS+0.1% Tween 20 then blocked with blocking
buffer (PBS, 1% BSA, 1 mM DTT, 0.1% Tween 20) for 2 hours
at room temperature. Then 750 uL of reaction mixture (PBS, 1%
BSA, 1 mM DTT, 5 mM MgCl2, 1% Triton-X-100, 1% glycerol,
0.33 ug/mL Alexa647-labelled hLNX1 PDZ2, 0.50 ug/mL
Alexa647-labelled hLNX1 PDZ3, 0.20 ug/mL Alexa647-labelled
hLNX1 PDZ4D3C) was pipetted over slides and incubated for
Figure 1. Schematic diagram of protein domains and carboxy
terminal residues of LNX1 and LNX2. Percentages represent amino
acid sequence identity between corresponding PDZ domains.
doi:10.1371/journal.pone.0026248.g001
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for 15 minutes each time with wash buffer (PBS, 1 mM DTT,
5 mM MgCl2, 0.5% Triton-X-100). Slides were left to dry
overnight in the dark. Fluorescence was visualized using a PE
ProScanArrayHT with 633 nm laser at 10 uM resolution. Spot
fluorescence was corrected for local background and normalized
using LOWESS normalization as available in the ProScanArray
Express software (Perkin Elmer). Quantitated spot fluorescence
was adjusted for the concentration of protein at each spot using
ProtoArray ProspectorH (Invitrogen). Every protein is spotted
twice on the human ProtoArrayH v4. A protein was considered a
hit on a given slide if both spots have an average Z-score of greater
than three and the coefficient of variation for the signals from the
two replicates is less than 0.5.
Yeast Two-Hybrid Screen
Expression of GAL4-DNA binding domain-mLNX fusion
protein in L40 yeast cells (MATa, his3D200, trp1–901, leu2–
3,112, ade2, LYS2::(lexAop)4-HIS3 URA3::(lexAop)8-lacZ) was
confirmed by western blot of transformed yeast cell lysate. The
yeast two-hybrid screen was performed as previously described [8].
Prey clones containing insert were selected for maxiprep (Qiagen),
sequenced and retransformed with pBTM116-mLNX to confirm
the interaction and determine specificity. Sequences were analysed
by BLAST and FASTA searches of GenBank. Matching or similar
sequences were verified with the PILEUP and BESTFIT programs
from the GCG Wisconsin package.
Identification of Additional LNX1 Interacting Proteins
We assembled a list of other LNX1 interactors by searching
published literature and interaction databases (GRID [30], UniHI
[31], Domino [32], and PDZbase [33]). The list of published and
potential LNX1 interactors contains 220 mammalian proteins.
Clustering by Gene Ontology Annotation
The set of 220 mammalian LNX1 interactors were clustered by
Gene Ontology Annotation (GOA) as previously described [34].
Briefly, the similarity scores (ranging from 0.0–1.0) for all pairs of
proteins in the set were calculated using the simUI method in R/
BioConductor and converted to dissimilarity scores (1.0-similarity).
The matrix of dissimilarity scores was used as input for
Partitioning Around Medoids (PAM) clustering in R/BioConduc-
tor. The R/BioConductor method silcheck was used to select k,
the number of clusters. The resulting clusters were visualized in
Cytoscape [35], where nodes represent proteins and edges
represent dissimilarity between proteins. As every protein in the
list is compared to every other protein in the list, an edge exists
between every pair of nodes. In order to improve visualization,
edges representing dissimilarity scores above 0.4 (BP, MF) or 0.3
(CC) were removed and dissimilarity scores close to 0 are shown as
darker, thicker edges. Circles of nodes represent proteins that were
clustered together. Each circle of nodes contains one larger node
that represents the medoid (i.e., the representative object) for that
cluster. The label for each cluster is a term selected from the set of
GO terms assigned to the medoid protein and found by manual
inspection to be representative of the GOA of the majority of the
remaining proteins in the cluster. The colour of each node was
randomly assigned by Cytoscape according to the GOA from the
corresponding GO aspect (BP, MF or CC).
Plasmids
Murine LNX1, LNX1C45A [11], LNX2, LNX2C51A were
cloned into pFLAG-CMV-2. Full length human AURKB, CDK2,
CAMK2N2, KCNA4, MAPKAP3, PLEKHG5, RASL11B,
ARVCF, PKC-alpha1, PAK6, and TYK2 and were cloned in
Gateway N-terminally tagged destination vector N-Myc.
Transfections and Co-immunoprecipitations
293T cells were maintained in 10% FBS in DMEM (Dulbecco’s
Modified Eagle Medium). Cells were transfected with 2 mg of each
plasmid and transfected at 50–60% confluency with 5–10 ug of
pFLAG-LNX1, pFLAG-LNX2 with or without N-myc tagged
cDNAs as described above, using OPTI-MEM and lipofectamine
2000 (GibcoBRL). After 24 hours, cells were lysed with HNTG-
ZE [11] containing protease inhibitors (Complete). 1 mg of total
protein was precleared with protein-G sepharose for 30 min and
then immunoprecipitated with 1 mg of anti-Myc antibody (9E10).
The beads were boiled for 5 min in SDS Sample buffer and
separated by SDS-PAGE, transferred to PVDF and immuno-
blotted with anti-Flag (M2, Sigma) or anti-Myc at 1:1000.
GST Fusion Protein Binding Experiments
Transfected 293T cell lysate (50–100 uL) was mixed with 3 ug
of purified GST fusion protein immobilized on glutathione
sepharose beads in a total of 1 mL PLC lysis buffer [8] for
90 min at 4uC. Sepharose beads were pelleted and washed five
times with 1 mL PLC lysis buffer. The beads were resuspended in
70 uL of 2xSDS sample buffer with 5% ß-mercaptoethanol and
boiled 5–7 min at 100uC. The samples were separated by 10%
SDS-PAGE, transferred to immobilon-P and western blot analysis
with an anti-myc antibody was performed to detect interactions.
Lipid Binding Experiments
Binding of GST-LNX1 and individual GST-LNX PDZ
domains to immobilized PIP lipids was performed according to
manufacturer’s protocol with some modifications. Briefly, PIP
Strip membranes (Echelon Biosciences) were blocked with TBS
containing 3% (w/v) Bovine Serum Albumin (BSA). Blocked
membranes were incubated with GST-LNX1 (0.025 mg/ml) and
GST-LNX1 PDZ domains (1 mg/ml) in TBS with 3% BSA, at
4uC overnight. Membranes were washed three times with TBS
containing 0.1% Tween-20 and then incubated with rabbit anti-
GST (2 mg/ml) in blocking solution for one hour at room
temperature. After washing three times with TBS with 0.1%
Tween-20, membranes were incubated with anti-rabbit HRP
(Horseradish Peroxidase) in blocking solution, washed, developed
using ECL (Enhanced Chemi-Luminescence, Amersham) and
exposed to film.
Results
LNX1 PDZ Domains Are Most Similar to LNX2 PDZ
Domains
A recent study demonstrated that the binding specificity for a
given PDZ domain can be reliably predicted from that of another
PDZ domain with known specificity if there exists sufficiently high
identity in the binding site sequence, as represented by 17 residues
that have contact with the ligand [36]. Specifically, binding site
sequence identity over 70% between PDZ domains predicts that
the two domains will have a similar binding specificity. In order to
determine if the binding specificity of the LNX1 PDZ domains
could be predicted, we performed BLAST searches of the NCBI
GenPept protein sequence database to identify the most similar
PDZ domains for each LNX1 PDZ domain. The strongest
similarity as measured by percent sequence identity for each of the
LNX1 PDZ domains was with the corresponding PDZ domain in
LNX2 (sequence identity range: 56–63%) (data not shown). The
LNX1 Interacting Proteins
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similarity score (sequence identity range: 35–48%). We examined
the sequence identity in the 17 residues identified as the binding
site sequence between each LNX1 PDZ domain and the respective
top three similar PDZ domains. PDZ1 and PDZ3 did not have
binding site sequence identity over 70% with any of the PDZ
domains examined. PDZ2 and PDZ4 had binding site sequence
identity over 70% with only LNX2 PDZ2 and PDZ4, respectively.
However, since the binding specificities for the LNX2 PDZ
domains are not yet known, we were not able to predict the
binding specificity for the LNX1 PDZ domains.
Identification of LNX1 PDZ Binding Proteins Using a
Protein Array Screen
In order to identify novel LNX1 PDZ domain binding targets
we screened Invitrogen ProtoArrayH v.4 slides with the isolated
PDZ domains of LNX1 expressed as GST fusion proteins. We
used custom printed protein arrays to optimize conditions for
LNX1 PDZ domain binding to immobilized fusion proteins. Test
protein arrays were printed with positive and negative control
proteins to confirm that Alexa 647-labelled GST-LNX1 PDZ
domains were able to bind to immobilized GST fusion proteins
but not GST alone. The fusion proteins GST, GST- Numb PTB+
and GST-Numb PTB- were printed on PATH slides at eight
concentrations ranging from 0–250 ng/uL. We found that the
individual hLNX PDZ domains bound to proteins on the protein
array with differing efficiency, therefore, different amounts of each
were used in the screen. Specifically, GST-hLNX PDZ4D3C
binding to positive controls was detectable at a lower concentra-
tion than binding by GST-hLNX PDZ3. Therefore, the final
screen utilized 0.33 mg/mL GST-hLNX PDZ2, 0.50 mg/mL
GST-hLNX PDZ3 and 0.20 mg/mL GST-hLNX PDZ4D3C.
Duplicate Invitrogen ProtoArrayH v.4 slides were treated
identically and probed with a mixture containing Alexa 647-
labelled GST-PDZ2, -PDZ3 and -PDZ4D3C (Figure 2). Slides
were scanned and analyzed according to manufacturer instruc-
tions. Since each protein was spotted twice on each protein array,
a protein was considered to interact with LNX1 if both spots met
the cut-off criteria (see Experimental Procedures). Slide 1 yielded
123 proteins and slide 2 had 96 proteins that met our criteria for
positive binding. Of these, 62 proteins were positive for LNX1-
PDZ domain binding on both slides (Table S1).
Of the 62 proteins identified as LNX1 PDZ domain binding
partners, four proteins corresponded to 39 untranslated regions of
cDNA, three proteins corresponded to cDNA that has been
removed from NCBI’s GenBank database due to standard genome
annotation, one protein corresponded to a cDNA that is
permanently suppressed in NCBI’s GenBank database as it is
now thought that this gene does not encode a protein and one
protein corresponded to a cDNA that is permanently suppressed
in NCBI’s GenBank database as it is a non-sense mediated decay
candidate. The 53 remaining proteins corresponded to annotated
proteins.
As it has been shown that some PDZ domains are able to
recognize and bind other PDZ domains, we searched the 53 hits
for proteins containing PDZ domains. We found that only one
protein, DEPDC6, that contains two DEP domains and one PDZ
domain. The very low number of hits containing PDZ domains
could indicate that LNX1 PDZ domains do not recognize other
PDZ domains, that the LNX1 PDZ domains do not recognize
other PDZ domains when expressed individually or that LNX1
PDZ domains are not able to effectively recognize other PDZ
domains in this assay format.
Among the 53 newly identified LNX1 PDZ binding proteins, 11
proteins were found to contain a kinase domain: DAPK1, PAK1,
CDK2, PLK3, AURKB, AURKC, MAPKAPK3, DYRK3,
EPHA8, EPHB3 and TRIB1 (Table S1). To determine if the
high number of kinase domain-containing proteins identified
simply reflected a high proportion of kinases on the protein array,
we searched the protein content list provided by Invitrogen for the
ProtoArrayH v.4. While 5.6% (448/8000) of the proteins on the
array were annotated as Protein Kinases, 17.7% (11/62) of LNX1
hits contain protein kinase domains. We calculated the fraction of
hits that are protein kinases using all hits (62) rather than only hits
that correspond to annotated proteins (53) since the percentage of
the 8000 proteins on the ProtoArrayH v.4 that correspond to
annotated proteins is unknown.
Inspection of the disease relationships of the 53 hits revealed 11
proteins that have previously been linked to tumours and/or
cancer (Table S1). The proteins DDX17, MPG and PAK1 have
been linked to colorectal cancer. Aberrant expression of AURKB,
MPG and SNCB has been observed in cancers of neuronal cell
types - gliomas, astrocytomas and medulloblastomas, respectively.
AURKC is known to be over expressed in several cancer cell lines
while DAPK1 is a tumour suppressor candidate. Finally, CDK2,
LST1, NKD2 and RASL11B have also been implicated in a
variety of cancer types.
We also identified three proteins, KCNA4 (Kv1.4), KCNAB1
and KCNAB2 that are voltage-gated potassium channel subunits
while another hit, ARPP-19, is able to act as a potassium channel
regulator. In addition, SCLT1 is known to be a sodium channel
subunit. This is in keeping with the observation that a number of
PDZ domain containing proteins are known to associate with and
regulate activity of transmembrane proteins and channels. Finally,
nine of the 53 hits are uncharacterized proteins containing either
no known domains or domains of unknown function.
Specificity of the LNX1 PDZ Domains
We examined the carboxy-terminal tails of all 62 proteins for
information about the binding selectivity of the LNX1 PDZ
Figure 2. Two Invitrogen ProtoArraysH v4 were incubated with
a mixture of the following Alexa647-fluorescently labelled
proteins: 0.33 ug/mL LNX1 PDZ2, 0.5 ug/mL LNX1 PDZ3 and
0.2 ug/mL LNX1 PDZ4D3C. (A,B) A sample grid (grid #43) is shown
from each of the two arrays. Reference spots for grid identification are
outlined in thin white rectangles. Thick yellow rectangles indicate LNX1
interactors identified on both protein arrays: BC004233.1 28AA in row 6
columns 3 and 4 and NM_172160.1 KCNAB1 in row 14 columns 3 and 4.
(B) Thick white rectangles indicate LNX1 interactors identified on only
one protein array: NM_020646.1 ASCL3 in row 5 columns 15 and 16,
NM_020548.4 DBI in row 11 columns 1 and 2, NM_153752.1
untranslated mRNA in row 14 columns 1 and 2, and NM_016096.1
ZNF706 in row 14 columns 7 and 8.
doi:10.1371/journal.pone.0026248.g002
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terminal tails that conform to an expanded list of PDZ domain
binding motifs based on Tonikian et al., [36] (Table 1). For 15 of
these proteins, the carboxy terminus of the protein spotted on the
ProtoArrayH v.4 corresponds to the predicited natural carboxy
terminus of the protein. Five of the 21 proteins (EphB3, DAPK1,
AURKC, NKD2, and KIAA1598) had artificially created carboxy
terminal tails as they were encoded by partial cDNAs, while one
protein (EBF4) contained a potential PDZ recognition motif but
does not correspond to an annotated protein. With respect to the
amino acid at the carboxy terminus (0 position), three of the 21
proteins we identified contained a cysteine at that position. While
not previously recognized as a canonical PDZ recognition motif,
LNX1 PDZ2 has previously been reported to select peptides with
a terminal cysteine residue [37], and more recently PDZ domains
from C. elegans and humans have been shown to preferentially
recognize motifs with a carboxy terminal cysteine [36]. The
remaining 17 carboxy terminal sequences conform more closely
with the major class of PDZ domain binding motif that have a
hydrophobic residue at the 0 position.
To further investigate the binding specificity of LNX1 PDZ2 we
superimposed the structure of LNX PDZ2 (PDB id: 2VWR) with
that of PSD-95 PDZ3 bound to a Class I PDZ ligand (PDB id:
1TP3), and modeled mutagenesis of the ligand’s carboxy terminal
valine to a cysteine residue using Coot [38]. This analysis showed
that a peptide with a carboxy terminal Cys residue could be
accommodated in the binding pocket of both LNX PDZ2 and
PSD95 PDZ3. Since the cysteine side chain is smaller than those
typically present in position 0 of Class I PDZ domains, we
measured the predicted distances between residues that form the
hydrophobic binding pocket and the carboxy terminal Cys
residue. We did not find any significant differences to suggest
that an additional contact helps stabilize a Cys peptide interaction
with LNX PDZ2 (data not shown). A search of the literature found
four additional PDZ domains reported to bind carboxy terminal
Cys peptides, from PDZ-RhoGEF, APBA3, SITAC and PTP-BL
proteins [36,39–41]. Using ClustalW, we compared the sequences
of 29 type I PDZ domains classified by Tonikian et al. [36] with
known Cys-peptide binding domains, as well as LNX1 PDZ2 and
LNX2 PDZ2. This analysis revealed that PDZ domains reported
to bind Cys-peptide are more closely related to each other than to
other Class 1 PDZ domains, based on primary sequence (Figure
S2). This suggests that regions other than the hydrophobic binding
pocket may contribute to stabilizing the interaction with Cys
containing peptides.
Assembly of a Comprehensive List of LNX1 Interactions
In addition to the protein array screen, we performed a yeast
two-hybrid screen with LNX1. Co-transformation of pBTM16-
mLNX1 with 100 ug of a mouse embryo heart and lung library
produced 1.5610
6 transformants. Of the 77 colonies that were
selected and restreaked from the library plates, 44 clones exhibited
ß-galactosidase activity. After eliminating false positives, out of
frame fusions and fusions with non-coding regions, we found six
clones that interacted with an individual LNX1 PDZ domain
(Table 2).
LNX1 has been included in several high-throughput interaction
screens identifying an additional 156 potential interaction
partners. Rual et al. tested all pair wise interactions of 7194
proteins from the human ORFeome collection in a high-
throughput yeast two-hybrid study [42]. LNX1 was used as both
bait and prey and interacted with 43 proteins [38]. In a screen
against a random peptide library in the yeast two-hybrid system,
Table 1. Carboxy terminal amino acids of selected ProtoArray LNX1 interacting proteins.
Protein Proto-array C-term sequence Wild-type C-term sequence
AMMECR1L RSV RSR SPH ESV* Not translated to protein
AURKB RVL PPS ALQ SVA* WT
AURKC GRA DPA FLY KVV* RRV LPP CAQ MAS*
C1ORF183 PSG FDI NTA VWV* WT
CAMK2N2 LKG MGE KPP SGV* WT
DAPK1 GRA DPA FLY KVV* TSY NSI SSV VSR*
DEPDC6 TIV MEV MEE LEC* WT
EBF4 SPA RGL QGL AYS* Not translated to protein
EPHB3 GRA DPA FLY KVV* RLQ MNQ TLP VQV*
IMAGE:4829245 DKA MLE LGP HIC* WT
KIAA1598 IEN VRE TDS SNC* AVD ELK GIL ASQ*
MGC18299 NKQ NYT KPT TSV* WT
MRPS24 QTV PSK VVY KYL* WT
MUSTN1 KPK AGP TKS VFG* WT
NKD2 WPG PFP SGL VAV* WT
PLEKHG5 LLL NST LTA SEV* WT
PPID DKE KAV YAK MFA* WT
RASL11B ALS AKV RTV TSV* WT
SCLT1 GEL NGQ LKY YQA* WT
SNCB PQE EYQ EYE PEA* WT
ZADH2 VVE LPH SVN SKL* WT
doi:10.1371/journal.pone.0026248.t001
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identify 107 predicted LNX1 PDZ2 interactors [37]. Finally, in a
screen of 157 mouse PDZ domains against 217 peptides based on
the carboxy termini of mouse proteins, four proteins were
identified as interactors for LNX1 PDZ2 [43]. None of the
LNX1-interacting proteins were found in common between these
studies, perhaps as a consequence of the different types of assays
used in the three screens. However, two interactors, PRA1 and
DDX17, were identified by both high-throughput yeast two-
hybrid [42] and our studies. We isolated PRA1 in our yeast two-
hybrid screen and DDX17 in our protein array screen. We used
the combined results to generate a list of 220 mammalian LNX1
interacting proteins for further analysis (Table S2).
Clustering LNX1 Interacting Proteins by Gene Ontology
Annotation
In order to reveal potential new roles for LNX1, the list of
putative LNX1 interacting proteins was clustered by associated
GOA (Figure 3) [34]. The resulting clusters were visualized in
Cytoscape; nodes represent proteins and edges represent the
strength of the GO similarity between pairs of proteins. This
analysis revealed well separated clusters, such as MF3, MF4, CC2
and CC8, which contain high similarity between the proteins
within each cluster. These clusters contain proteins that are highly
related to each other but not to proteins from other clusters.
Several adjacent clusters such as BP1–BP2 and MF1–MF2 are not
well separated and have many edges between two clusters in
addition to those within the cluster. These clusters contain proteins
that are closely related to proteins from two different clusters. This
phenomenon has been observed in all clustering by GOA as
performed using our method and is believed to reflect the current
level of granularity of GO itself. As both GO and the number of
proteins that have GOA grow, clustering by GOA is expected to
produce better separated clusters.
Validation of Novel LNX1 PDZ Binding Proteins
Two clusters were selected as having GOA trends of biological
interest: MF1 – Structural molecule activity (containing 20
proteins) and MF4–Serine/threonine kinase activity (containing
30 proteins). To determine whether interactions identified in the
protein array and other high-throughput screens could be verified
by co-immunoprecipitation, we obtained cDNAs corresponding to
14 proteins for further study. We selected three proteins from
MF1, seven proteins from MF4 (protein serine/threonine kinase
activity), as well as one protein from MF7 (voltage-gated ion
channel activity), one protein from MF9 (receptor activity) and two
proteins that did not have GOA (Table 3). These cDNAs were
subcloned into a myc tagged mammalian expression vector and
cotransfected with FLAG-tagged LNX1, LNX1C45A (inactive
ubiquitin ligase), LNX2, LNX2 C51A (inactive ubiquitin ligase) or
empty vector control. LNX1 family proteins were found to
immunoprecipitate with KCNA4, PAK6, PLEKHG5, PKC-
alpha1, TYK2, and PBK (Figure 4) while AURKB, CDK2,
CAMK2N2, MAPKAPK3, Claudin1 and Claudin3 did not
coimmunoprecipitate (data not shown). Four of the confirmed
interacting proteins contain classic S/T- X-V binding motifs while
the remaining two, PAK6 and TYK2, contain a novel class of
PDZ binding motif with a cysteine in the 0 position (S-X-C)
(Figure 4). Different patterns of target binding to LNX1, LNX2
and their respective ligase inactive forms, was observed in these
experiments. The C45A mutation within the RING domain is
thought to disrupt its interaction with E2 enzymes and we have
shown that this mutation abolishes LNX1 ability to ubiquitinate
Numb [7]. This might be expected to stabilize certain interactions
in which the binding target is also a substrate. Alternatively, as this
mutation disrupts interaction with E2 enzymes by unfolding the
RING domain, it could also cause disruption in the folding of
other nearby regions, including the PDZ domains, important for
target binding.
We then investigated which of the LNX1 PDZ domains were
able to recognize the coimmunoprecipitated proteins described
above by performing GST-fusion pull downs with isolated LNX1
PDZ domains (Figure 5). GST-PDZ1 was able to bind KCNA4
and PLEKHG5. GST-PDZ2 recognized PKC-alpha1, TYK2,
and PAK6. GST-PDZ3 bound only PLEKHG5 while GST-PDZ4
recognized PKC-alpha1 and PAK6 (Figure 5). PBK was not
recognized by any individual LNX1 PDZ domains (data not
shown).
Next we used the carboxy terminal residues of the proteins
recognized by individual LNX1 PDZ domains to search the list of
220 LNX1 interactors for other proteins that have similar carboxy
termini (Table S3). Allowing for conservative amino acid
substitutions in the final three residues of the protein, 28 proteins
were identified. Of the 28 proteins, 27 were predicted LNX1
interactors from the phage-display random peptide library screen
[37] while the remaining protein was identified in our protein
array screen.
Investigation of LNX1 PDZ Domain Lipid Binding
Specificity
As PDZ domains have also recently been shown to interact with
membrane phosphoinositides (PI) [4,44–46], we investigated the
phospholipid binding of the individual LNX1 PDZ domains. Using
membranes containing various immobilized phospholipids, we
found that full length LNX1 and the isolated LNX1 PDZ4 bound
specifically to PIPs but not to other phospholipids (Figure 6A).
Table 2. LNX1 interacting proteins from yeast two-hybrid screen.
Protein Entrez Gene ID Description C-terminus
WWP1 11059 WW containing E3 ubiquitin ligase FAIEETEGFGQE
NG23 401251 Chromosome 6 open reading frame 26 GCTKGPRGPTRV
PRA1 10567 RABAC1; prenylated Rab acceptor AVDGEELQMEPV
TP14C 51522 transmembrane protein 14C AKVGVSMFNRPH
WAC 51322 WW domain containing adaptor with a coiled
coil region
LEKLKNQNSFMV
Syntaxin5 6811 syntaxin 5A IVFFIIFVVFLA
doi:10.1371/journal.pone.0026248.t002
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and PDZ2 did not bind detectably to any phospholipids on the
membrane. In support of the observation that PDZ4 recognizes
PIPs while PDZ2 does not, a sequence alignment of PDZ2 and
PDZ4 with hPar3 PDZ2, a PDZ domain known to bind PIPs,
revealed that many of the residues that form a positive charge
cluster important for PIP binding by PAR3 are conserved in LNX1
PDZ4 but not in LNX1 PDZ2 (Figure 6B) [46].
Discussion
In this study, protein array and yeast two-hybrid screens were
performed to identify binding partners for the PDZ domains of the
E3 ubiquitin ligase LNX1. We combined our data with that of
published reports to develop a comprehensive list of potential
LNX1 binding partners. Computational analysis of this large data
set has further defined the LNX1 PDZ domain specificities, and
cluster analysis based on Gene Ontology annotation has revealed
potential new biological roles for LNX1.
In addition to the protein array screen performed here, two other
published accounts used LNX1 as bait for high-throughput screens
of defined libraries. In Rual et al. a high-throughput yeast two-
hybrid screen, 7194 human Entrez Gene IDs were provided for the
defined library [42]. In our protein array screen, there were 6740
molecules for which human Entrez Gene IDs could be identified. In
Stiffler et al. a screen of immobilized peptides based on mouse
proteins, human Entrez Gene IDs could be found for 181 of 217
molecules [43]. Of these, only one protein was found in common
Figure 3. Clustering by GO annotation similarity. 220 LNX1 interacting proteins were clustered according to the graph similarity of their GO
annotation. Nodes represent proteins; lines between nodes represent the similarity of GO annotation between two proteins with thick dark lines
representing high similarity and thin light lines representing lower similarity scores. Node colours represent GO annotation and were randomly
assigned by Cytoscape. Proteins are grouped together in circles according to their clusters, i.e. circle 1=cluster 1. (A) Proteins clustered according to
the similarity of their GO Biological Process annotation, clusters BP1–BP9. (B) Proteins clustered according to the similarity of their GO Molecular
Function annotation, clusters MF1–MF9. (C) Proteins clustered according to the similarity of their GO Cellular Component annotation, clusters CC1–
CC9.
doi:10.1371/journal.pone.0026248.g003
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results is consistent with observations from other high-throughput
screencomparisons[47,48].Inpart,thiscanbebecausethe libraries
screened did not contain the same target proteins or may reflect
species divergence in the libraries used. In addition, although the
same target proteins may be present in the library, different binding
conditions used in each screen could also result in unique subsets of
proteins that are recognized by the bait molecule. We compared the
molecules contained in these three defined libraries used for LNX1
interaction screens and found that on average about half the
proteins in a given library are found in one or both of the other two
libraries. When we searched for proteins that were recognized by
LNX1 in any one of these screens, we found that there was greater
potential for overlap than was actually observed. Specifically, 26 of
the 43 molecules identified in the yeast two-hybrid screen [42] were
contained in the protein array library (this study) while none of the
43 molecules werefound in the peptidelibrary[37]. Thisunrealized
potential for overlap in the screen results illustrates the varying
ability of the same bait molecule to bind to the same target
molecules under different screen conditions.
Figure 4. Confirmation of novel LNX1 and LNX2 binding partners by co-immunoprecipitation. Flag-tagged LNX1, LNX1 C45A (inactive
ubiquitin ligase), LNX2 or LNX2 C51A (inactive ubiquitin ligase) were cotransfected with Myc-tagged candidates into 293T cells. Cell lysates were
immunoprecipitated with anti-Myc antibody and blotted with anti-Flag to identify novel interactions.
doi:10.1371/journal.pone.0026248.g004
Table 3. Proteins selected for testing by co-immunoprecipitiation.
Protein Entrez Gene ID Description Carboxy-terminus Source MF cluster
ARVCF 421 armadillo repeat protein deleted in
velocardiofacial syndrome
GDAKPQPVDSWV MCP 2006 5:1368 1
claudin-1 9076 tight junctions between epithelial cells PAPSSGKDYV MCP 2006 5:1368 1
Claudin-3 1365 tight junction protein, low affinity receptor for
Clostridium perfringens enterotoxin
GTGYDRKDYV MCP 2006 5:1368 1
AURKB 9212 Aurora kinase B RVLPPSALQSVA ProtoArray screen 4
CDK2 1017 Cyclin-dependent kinase 2 QDVTKPVPHLRL ProtoArray screen 4
MAPKAPK3 7867 Mitogen-activated protein kinase-activated
protein kinase 3
GSSSASQGCNNQ ProtoArray screen 4
PAK6 56924 serine/threonine-protein kinase QLYRKQTSTC MCP 2006 5:1368 4
PBK 55872 PDZ-binding kinase HIVEALETDV MCP 2006 5:1368 4
TYK2 7297 non-receptor tyrosine-protein kinase GQAPSVFSVC MCP 2006 5:1368 4
PKC 5578 Protein Kinase C alpha PQFVHPILQSAV Science 2007 317:364 4
KCNA4 3739 potassium channel Kv1.4; KCNA4; human
NM_002233
NCSNAKAVETDV MCP 2006 5:1368 7
PLEKHG5 57449 Pleckstrin homology domain containing family G
(with RhoGEF domain) member 5
LLLNSTLTASEV ProtoArray screen 9
RASL11B 65997 Ras-like family 11 member B ALSAKVRTVTSV ProtoArray screen
CAMK2N2 94032 Calcium/calmodulin-dependent protein kinase II
inhibitor 2
LKGMGEKPPSGV ProtoArray screen
doi:10.1371/journal.pone.0026248.t003
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intracellular proteins SKIP [26], Src [27] and Numb [12]. The
ability of PDZ1 to recognize only the isoforms of Numb that are
ubiquitinated by LNX1 [12] suggests that PDZ1 may play an
important role in substrate recognition or orientation relative to
the E2-bound RING domain of LNX1. We found that LNX1
PDZ1 is able to recognize two novel binding partners, KCNA4
and PLEKHG5. KCNA4 is a shaker-type voltage-gated K
+
channel [49,50]. To our knowledge, this is the first time that
LNX1 PDZ1 has been verified to bind a transmembrane protein
and the first time that any PDZ domain of LNX1 has been found
to interact with an ion channel protein. The carboxy terminal tails
of both KCNA4 and PLEKHG5 fit a traditional PDZ binding
motif (S/T-X-V) whereas SKIP, Src and Numb do not. As LNX1
PDZ1 also binds to an internal site in the Numb PTB domain
[12], it is possible that PDZ1 recognizes both canonical PDZ
domain binding motifs as well as internal sites on other protein
targets.
LNX1 PDZ2 has been found to bind both intracellular and
transmembrane targets [13,14,16] and has been predicted to bind
a number of other proteins [37,43]. Here we confirmed predicted
interactions with Tyk2 and PAK6, and identified a novel
interaction partner, PKC-alpha1. Tyk2, PAK6 and PKC-alpha1
are all protein kinases. TYK2 is a member of the Janus kinase
(JAK) family of cytoplasmic protein tyrosine kinase [51,52] while
PAK6 and PKC-alpha1 are serine/threonine kinases associated
with a wide variety of cellular processes including signal
transduction, cell proliferation and apoptosis [53–59]. The ability
of LNX1 PDZ2 to bind a wide variety of cytoplasmic and
transmembrane proteins including protein kinases suggests that
this domain plays a critical role in recruiting components to the
LNX1 signal transduction complex. The screen of a random
peptide library using LNX1 PDZ2 predicted that PDZ2 would
select proteins with a cysteine residue in the carboxy terminal
position [37] and a recent random peptide library screen also
revealed that PDZ domains from several other proteins select
binding motifs with a carboxy terminal cysteine [36]. Here we
confirmed by coimmunoprecipitation and GST pull down
experiments that LNX1 PDZ2 is able to bind Tyk2 and PAK6,
two proteins that contain a carboxy terminal cysteine residue.
The first published binding partner for LNX1 PDZ3 was the
proto-oncogene c-Src, a cytoplasmic protein tyrosine kinase [28].
Although the interaction between LNX1 and Src was identified
Figure 5. Interaction of individual LNX1 PDZ domains with
novel binding partners as tested by fusion protein binding
experiments. Each PDZ domain of LNX1 was fused to GST. Purified
fusion proteins were incubated with 293T cell lysate transfected with
the myc-tagged protein indicated at left. Interactions were detected by
immunoblotting with anti-myc antibody.
doi:10.1371/journal.pone.0026248.g005
Figure 6. LNX1-lipid binding. (A) Binding of purified LNX1 or GST-LNX1 PDZ1, 2, 3 or 4 to phosphatidylinositol phosphate lipids immobilized on
membrane strips (Echelon Biosciences) was assessed by anti-LNX1 or anti-GST immunoblot. Exposure times of individual membrane strips were:
LNX1, 1 seconds.; PDZ1, 30 min.; PDZ2, 1 min.; PDZ3, 30 min., PDZ4, 15 seconds. (B) Sequence comparisons of LNX1 PDZ 2 and 4 and the lipid
membrane-binding PDZ 2 of Par3. Residue positions shown to be critical for forming a positive charge cluster (m) or the binding pocket for the
phosphatidylinositol head group (*) in Par3 PDZ 2 are indicated.
doi:10.1371/journal.pone.0026248.g006
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interaction with Src. These authors also demonstrated that LNX1
is phosphorylated by Src and that Src is ubiquitinated by LNX1.
These findings support our previous findings that PDZ1 is
important for recognition of ubiquitination targets [12]. Here we
identified an interaction between LNX1 PDZ3 and PLEKHG5.
Similar to Src, PLEKHG5 is also able to bind to PDZ1.
Therefore, PDZ1 and PDZ3 may bind to similar targets
potentially increasing LNX1 substrate avidity.
Previously, no ligands have been identified for LNX1 PDZ4.
Here we identify two protein ligands, PKC-alpha1 and PAK6, as
well as multiple PIPs as ligands for PDZ4. Both PKC-alpha1 and
PAK6 also interact with PDZ2. Only PDZ4 was able to bind to
PIPs, suggesting that an important function of PDZ4 is to interact
with membrane phospholipids that may influence LNX1 subcel-
lular localization. Interestingly, a similar binding specificity has
been observed for PTP-BL (Protein Tyrosine Phosphatase -
Basophil Like) PDZ5, i.e., very few protein interactors and the
ability to bind phospholipids [60].
Our work has shown that each PDZ domain of LNX1
contributes a specific element to the overall function of LNX1 as
a signal transduction complex scaffold. We also considered that as
components of a scaffold protein, individual PDZ domains of LNX
may interact with distinct elements of a single pathway. Analysis of
the list of 220 LNX interacting proteins using Reactome Pathway
Analysis (http://www.reactome.org) highlighted two pathways
that are statistically over represented. This analysis suggests a role
for LNX1 in tight junction organization through association with
claudin family members as well as a potential role for LNX1 in
GAP junction trafficking and regulation. Future work to identify
the specific molecules present in the LNX1 multi-protein signalling
complex in different cell types will be needed to elucidate LNX1
functions.
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